Cargando…

Immunotherapies for Pediatric Solid Tumors: A Targeted Update

There are encouraging signs in our collective progress to leverage the immune system to treat pediatric cancers. Here, we summarize interim successes in cancer immunotherapy and opportunities to translate from the adult world to pediatrics, and highlight challenges that could benefit from additional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ajay, Cripe, Timothy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Current Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613512/ https://www.ncbi.nlm.nih.gov/pubmed/34822115 http://dx.doi.org/10.1007/s40272-021-00482-y

Ejemplares similares

Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
por: Paliard, Xavier, et al.
Publicado: (2019)

Drug Exposure and the Risk of Microscopic Colitis: A Critical Update
por: Lucendo, Alfredo J.
Publicado: (2017)

Can Pediatric Heart Failure Therapy Be Improved? Yes It Can, But…
por: Schranz, Dietmar
Publicado: (2022)

Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?
por: Underhill, Hunter R.
Publicado: (2021)

Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022)

The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016
por: Mathur, Anthony, et al.
Publicado: (2017)

Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution
por: Land, Walter Gottlieb
Publicado: (2020)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
por: Hausenloy, Derek J., et al.
Publicado: (2017)

The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets
por: Casucci, Gerardo, et al.
Publicado: (2020)

‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
por: Annemans, Lieven, et al.
Publicado: (2018)

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
por: Kjeldsen, Sverre E., et al.
Publicado: (2014)

Extended Adjuvant Therapy with Imatinib in Patients with Gastrointestinal Stromal Tumors: Recommendations for Patient Selection, Risk Assessment, and Molecular Response Monitoring
por: Rutkowski, Piotr, et al.
Publicado: (2013)

24-Hour Physical Behavior Balance for Better Health for All: “The Sweet-Spot Hypothesis”
por: Holtermann, Andreas, et al.
Publicado: (2021)

Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
por: Mahfoud, Felix, et al.
Publicado: (2020)

Allergen-specific immunotherapy in pediatric allergic asthma
por: Yukselen, Ayfer
Publicado: (2016)

Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
por: Watras, Magdalena M., et al.
Publicado: (2016)

Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic
por: Asukai, Yumi, et al.
Publicado: (2021)

NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View
por: Angoulvant, Denis, et al.
Publicado: (2021)

The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum
por: McCarthy, Cian P, et al.
Publicado: (2017)

A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment
por: Sullivan, Tim, et al.
Publicado: (2022)

Interchangeability for Biologics is a Legal Distinction in the USA, Not a Clinical One
por: Park, Joseph P., et al.
Publicado: (2022)

Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite
por: Gupta, Ajay, et al.
Publicado: (2020)

‘Step Up’ approach to the application of REBOA technology in a rural trauma system
por: Vernamonti, Jack P, et al.
Publicado: (2019)

Fuel for the Work Required: A Theoretical Framework for Carbohydrate Periodization and the Glycogen Threshold Hypothesis
por: Impey, Samuel G., et al.
Publicado: (2018)

Measurement of Energy Intake Using the Principle of Energy Balance Overcomes a Critical Limitation in the Assessment of Energy Availability
por: Tarnowski, Caroline A., et al.
Publicado: (2023)

Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics
por: Boden, William E, et al.
Publicado: (2020)

Developing Decision-Making Expertise in Professional Sports Staff: What We Can Learn from the Good Judgement Project
por: Wilson, P. J., et al.
Publicado: (2023)

Confusion: Acetaminophen Dosing Changes Based on NO Evidence in Adults
por: Krenzelok, Edward P., et al.
Publicado: (2012)

The Importance of Countering Biosimilar Disparagement and Misinformation
por: Cohen, Hillel P., et al.
Publicado: (2020)

Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke
por: Appleton, Jason P., et al.
Publicado: (2016)

Assessments of the Value of New Interventions Should Include Health Equity Impact
por: Jansen, Jeroen P., et al.
Publicado: (2022)

Does Regular Physical Activity Mitigate the Age-Associated Decline in Pulmonary Function?
por: Burtscher, Johannes, et al.
Publicado: (2022)

Future Evolution of Biosimilar Development by Application of Current Science and Available Evidence: The Developer’s Perspective
por: Cohen, Hillel P., et al.
Publicado: (2023)

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
por: Turakhia, Mintu P, et al.
Publicado: (2018)

Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy
por: Burton, G.J., et al.
Publicado: (2009)

Macroeconomic trends and practice models impacting acute care surgery
por: Bernard, Andrew, et al.
Publicado: (2019)

Pediatric Cancer Immunotherapy: Opportunities and Challenges
por: Wedekind, Mary Frances, et al.
Publicado: (2018)

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
por: Ference, Brian A, et al.
Publicado: (2018)

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Ethical Considerations for the Participation of Children of Minor Parents in Clinical Trials
por: Ott, Mary A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ln0nh1n46nrcr8ril89o700eop